Doxercalciferol
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Is There Real Progress?
- Ultragenyx and Kyowa Kirin Announce US FDA Approves Label
- Alfacalcidol in CKD-MBD - a 5993; Mobile: 45 2054 2458; Email
- Crysvita Start Guide
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Control of Secondary Hyperparathyroidism by Vitamin D Receptor Agonists in Chronic Kidney Disease
- G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes
- Australian Statistics on Medicines 2009
- Cinacalcet (Sensipar) Reference Number: ERX.SPA.137 Effective Date: 03.01.14 Last Review Date: 08.18 Revision Log
- The Hectorol® Solution
- Article a Randomized Multicenter Trial of Paricalcitol Versus Calcitriol For
- HECTOROL (Doxercalciferol) Capsule, Liquid Filled [Genzyme Corporation]
- Class Review: Vitamin D Analogs
- Vitamin D and Glomerulonephritis
- Guidelines for ATC Classification and DDD Assignment 2021
- (12) Patent Application Publication (10) Pub. No.: US 2004/0053894 A1 Mazess Et Al
- Supplementary Table 3